China is on lockdown, and the whole world is watching developments about the coronavirus in real-time. Yet amidst the fear and panic, there’s a surprising consequence: students and workers who are effectively captive...
The Global Synthetic Biology Summit
September 29 - October 1, 2020
Bay Area - California, The Oakland Marriott
The Global Synthetic
Biology Summit
Biology Summit
September 29 - October 1, 2020
Bay Area - California, The Oakland Marriott
As Coronavirus Spreads, House-bound Chinese Students Are Causing An Online Ed-Tech Boom
Living amongst the coronavirus control measures in Beijing, the slogan in vogue is “stop school, but don't stop studying”. China's ed-tech industry is booming as the country's demand for online learning resources surges.
Bio-Nylon Is The New Green: How One Company Is Fermenting A $10 Billion Market
In the inevitable shift away from fossil fuels, Genomatica announced the first commercial production of bio-based nylon. Companies that seize the economic and environmental benefits of biomanufacturing stand to lead the way, whether it’s fabrics or face creams.
Twist Bioscience Market Cap Up 18% To $1.1B On Settlement Of Legal Dispute With Agilent
Twist Bioscience, led by CEO Emily Leproust, is enjoying a stock lift after announcing increased revenues and settlement of a trade secret lawsuit filed by Agilent Technologies. Investors may feel more confident in Twist’s prospects in silicon-based DNA manufacturing - a big component of the synthetic biology industry.
IndieBio’s Class Nine: Archetypes of Engineering Biology
On February 6, 2020, the eleven members of IndiBio’s Class Nine took the stage, revealing the ways they are engineering biology to optimize our immune systems, leverage the microbes that call our bodies home, make food ingredients and plastics more sustainable, and solve food production challenges.
Editors' picks
Twist Bioscience Market Cap Up 18% To $1.1B On Settlement Of Legal Dispute With Agilent
One of the biggest synthetic biology companies is enjoying a stock lift on settling a nagging trade secrets lawsuit. Twist Bioscience, a synthetic DNA manufacturer serving a wide range of industries, has announced...
China’s Plan To Beat The U.S. In The Trillion-Dollar Global Bioeconomy
The U.S. bioeconomy is now worth almost $1 trillion USD, and it got there by smart government investment, smart policies, and smart money. But a new national report, citing SynBioBeta data, warns that international...
